Cancer-killing treatment using a common cold virus offers hope to patients with inoperable tumors 

Cancer-killing treatment using a common cold virus offers hope to patients with inoperable tumors Phase I clinical trial announced Friday was conducted at NYU Langone Health Used a combination of a live cold virus with an immunotherapy drug  Treatment shrank melanoma tumors in 47% of the trial’s 36 participants  Several studies have examined how oncolytic viruses can … Read more